{"id":"W4378978155","doi":"10.1016/j.msard.2023.104786","title":"Beyond the B-cell as a treatment target in multiple sclerosis","year":2023,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"","keywords":"Ocrelizumab; Medicine; Multiple sclerosis; Ofatumumab; Internal medicine; Natalizumab; Dermatology; CD20; Rituximab; Immunology; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02574578,0.005855646,0.009732303,0.005431745,0.004418185,0.01055768,0.006344418,0.03245549,0.007494571],"category_scores_gemma":[0.04582751,0.002450784,0.00498102,0.002656161,0.004539209,0.007235798,0.002246846,0.03596546,0.006015131],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005816341,"about_ca_system_score_gemma":0.005112885,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003485809,"about_ca_topic_score_gemma":0.008090202,"domain_scores_codex":[0.986397,0.004599388,0.002406208,0.001034241,0.004934696,0.0006285285],"domain_scores_gemma":[0.9314347,0.04532468,0.002920292,0.00126428,0.01371007,0.005346056],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000177941,0.00002659469,0.00003520477,0.000859153,0.0001142643,0.0001548328,0.0000199819,0.0000353221,0.00007025108,0.0004501058,0.9918412,0.00621501],"study_design_scores_gemma":[0.0007132231,0.0001797992,0.0008346346,0.00268559,0.0007583156,0.0006986234,0.0001222186,0.0006775635,0.0002329937,0.004276315,0.9887322,0.00008851026],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.00002386522,0.01574773,0.0001005082,0.02976651,0.9537438,0.00001814435,0.0000329407,0.00003155589,0.0005348421],"genre_scores_gemma":[0.0002840339,0.007124326,0.00008410257,0.02407769,0.9663324,0.00002220807,0.00001374569,0.00001727794,0.002044197],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.03245549,"threshold_uncertainty_score":0.1361583,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03763177313008521,"score_gpt":0.2723908189235822,"score_spread":0.234759045793497,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}